Endometrial Cancer: Aberrations in Signaling Pathways and Targeted Intervention| Chapter 2 | Challenges and Advances in Pharmaceutical Research Vol. 10

 Endometrial malignant growth is the most coarse form of uterine cancer that has been accumulating more than four lakh cases occurring to the list of gynaecological cancers, with extreme economic countries spiking up the pace. However, underdeveloped countries, including India, further show a significant number of cases. As this anomaly is guide excessive estrogen- corpulence, PCOD, estrogen-secreting tumors, menarche at an early age and menopause at a late age are few of the major risk factors donating to its cause. Changes at the hereditary level and deteriorated indicating pathways pave the way for the development of endometrial tumor. Alterations in PI3K/PTEN/AKT pathway have happened implicated primarily in TYPE I of endometrial tumor, whereas the main changed pathway being the reason for TYPE II is p53/p16 pathway, among remainder of something. Various treatment plannings targeting these particular indicating pathways are in different phases of tests, and some have proved promising results too. So, cultivating targeted analyses based on distinguishing molecular pathways would aid in a good response rate and better forecast for endometrial cancer sufferers.

Author(s) Details:

Ritu Yadav,
Department of Genetics, Maharshi Dayanand University, Rohtak (Haryana), 124001, India.

Parul Ahuja,
Department of Genetics, Maharshi Dayanand University, Rohtak (Haryana), 124001, India.

Nancy Lathwal,
Department of Genetics, Maharshi Dayanand University, Rohtak (Haryana), 124001, India.

Preeti Chauhan,
Department of Biotechnology, Chandigarh Group of Colleges, Landran, Mohali (Chandigarh); -140307, India.

Please see the link here: https://stm.bookpi.org/CAPR-V10/article/view/8796

Endometrial Cancer: Histopathology and Diagnostic Procedures| Chapter 1 | Challenges and Advances in Pharmaceutical Research Vol. 10

 Endometrial malignancy (EC) is one of the most prevalent types of female cancers. The incidence and death from EC has been observed to increase in current decades. Abnormal bleeding, foul vaginal discharge, trouble or pain during urination, pain all along copulation, surprising weight loss, pain in lower tummy and legs, proneness in body etc. are the main signs and symptoms of EC. Age, nulliparity, Polycystic ovary condition, obesity, tamoxifen use, early menarche, late midlife depression, diabetes, high blood pressure, kill syndrome, cowden condition etc. are the major risk factors when in fact physical activity, dignified multiparity, combined contraceptive pills and hot acts as the protective determinants in EC. The diagnosis of this affliction mainly happens at later stages due to the late appearance of manifestations hence the state-of-the-art methods of early diagnosis are necessary to be grown. Here are described the histopathological types and subtypes of EC along with the ordinarily used demonstrative procedures that will help to understand the existent strategies and further aid in evolving efficient and accurate early discovery methods.

Author(s) Details:

Ritu Yadav,
Department of Genetics, Maharshi Dayanand University, Rohtak (Haryana)-124001, India.

Shalu Ranga,
Department of Genetics, Maharshi Dayanand University, Rohtak (Haryana)-124001, India.

Vaishali Yadav,
Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi-110070, India.

Chetna Yadav,
Department of Genetics, Maharshi Dayanand University, Rohtak (Haryana)-124001, India.

Please see the link here: https://stm.bookpi.org/CAPR-V10/article/view/8795

Obesity and Endometrial Cancer | Chapter 8 | Innovations in Medicine and Medical Research Vol. 4

 

In developed and westernized countries such as the United States, endometrial cancer (EC) is the
most common gynecological cancer with incidence rates being as much as 10 times higher than other
cultures. The majority of women present with postmenopausal and abnormal perimenopausal
bleeding, and almost 75% of these patients are in the early disease stage, yet the death rate has
risen. Also, an unprecedented increase in obesity prevalence rates has occurred. This article reviews
current research as to the relation between endometrial cancer and this disease’s major risk factor of
excess body weight.

Author(s) Details
 
Dr. A. M. Tacón,
Department of Health, Exercise and Sport Sciences, College of Arts and Sciences, Texas Tech University, Lubbock, Texas, USA.

View  Book :-  https://bp.bookpi.org/index.php/bpi/catalog/book/243